This Action aims at using innovative translational research to identify colorectal cancer biomarkers for personalized medicine that will improve screening, early detection and disease follow-up, and attain better tumor profiling, state-of-the-art functional characterization of genetic variants and new therapy approaches
Events
Meetings
Skopje, Macedonia
28th February 2019 13h-18h, 1st March 2019 9-17h
Management Committee + Working Groups Meeting
More about "Management Committee + Working Groups Meeting"
News
Using genetics to gauge colorectal cancer risk
Tuesday, 20 November 2018
Discoveries by a COST Action linking genetic make-up with the risk of colorectal cancer have been published in the British Journal of Cancer - reaching some 9 million scientists and resulting in the creation of a new COST network.
More about "Using genetics to gauge colorectal cancer risk"
